ACAT1 and neoplasm: In an animal study, a cancer stem cell antigens-loaded DC (CSCs-DC) vaccine was combined with an ACAT1 inhibitor to test the improvement of this treatment for HNSCC tumor recurrence and post-operative metastasis.